RT Journal Article
SR Electronic
T1 Universal PCR and antibody testing demonstrate little to no transmission of SARS-CoV-2 in a rural community
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.15.20175786
DO 10.1101/2020.08.15.20175786
A1 Appa, Ayesha
A1 Takahashi, Saki
A1 Rodriguez-Barraquer, Isabel
A1 Chamie, Gabriel
A1 Sawyer, Aenor
A1 ,
A1 Duarte, Elias
A1 Hakim, Jill
A1 Turcios, Keirstinne
A1 Vinden, Joanna
A1 Janson, Owen
A1 Manglik, Aashish
A1 Peluso, Michael J.
A1 Deeks, Steven G.
A1 Henrich, Timothy J.
A1 Torres, Leonel
A1 Rodgers, Mary
A1 Hackett, John
A1 Chiu, Charles
A1 Havlir, Diane
A1 Greenhouse, Bryan
YR 2020
UL http://medrxiv.org/content/early/2020/08/17/2020.08.15.20175786.abstract
AB Background The absence of systematic surveillance for SARS-CoV-2 has curtailed accurate appraisal of transmission intensity. Our objective was to perform case detection of an entire rural community to quantify SARS-CoV-2 transmission using PCR and antibody testing.Methods We conducted a cross-sectional survey of the prevalence and cumulative incidence of SARSCoV-2 infection in the rural town of Bolinas, California (population 1,620), four weeks following shelter-in-place orders. Residents and county essential workers were tested between April 20th – 24th, 2020. Prevalence by PCR and seroprevalence combining data from two forms of antibody testing were performed in parallel (Abbott ARCHITECT IgG to nucleocapsid protein and in-house IgG ELISA to the receptor binding domain).Results Of 1,891 participants, 1,312 were confirmed Bolinas residents (>80% community ascertainment). Zero participants were PCR positive. Assuming 80% sensitivity, it would have been unlikely to observe these results (p< 0.05) if there were > 3 active infections in the community. Based on antibody results, estimated prevalence of prior infection was 0.16% (95% CrI: 0.02%, 0.46%). Seroprevalence estimates using only one of the two tests would have been higher, with greater uncertainty. The positive predictive value (PPV) of a positive result on both tests was 99.11% (95% CrI: 95.75%, 99.94%), compared to PPV 44.19%-63.32% (95% CrI range 3.25%-98.64%) if only one test was utilized.Conclusions Four weeks following shelter-in-place, active and prior SARS-CoV-2 infection in a rural Northern California community was extremely rare. In this low prevalence setting, use of two antibody tests increased the PPV and precision of seroprevalence estimates.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.medrxiv.org/content/10.1101/2020.05.29.20116426v1 Funding StatementThis work was primarily supported by the Bolinas Community Land Trust (DH, BG). Additional sources of support included funding from the Chan Zuckerberg Biohub Investigator program (BG) and the National Institutes of Health grant 5T32AI007641-17 (AA).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was submitted to UCSF Institutional Review Board: IRB number 20-30636.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSee Appendix 1 for more detailed explanation of statistical methods; additionally, code to reproduce all analyses are available at: https://github.com/EPPIcenter/bolinas-analysis. https://github.com/EPPIcenter/bolinas-analysis